Read the latest news stories in diabetes tech, research and innovation.
Future Tech
+3
/
Sep 15, 2025
This continuous glucose monitor promises multi-sensor health tracking and is aiming for a mid-2026 launch
+5
Sep 5, 2025
Tandem’s Sigi patch pump in development would be rechargeable, use refillable insulin cartridges, and be waterproof — our video covers what we know so far.
+2
Sep 4, 2025
The latest Series A funding brings Luna's bedtime patch pump, for MDI users, one step closer to reality.
Medtronic
Sep 2, 2025
Medtronic's SmartGuard algorithm is cleared for the upcoming 15-day Instinct CGM and the MiniMed 780G gets clearance for type 2 diabetes.
Aug 27, 2025
London startup SAVA reports early results from its non-invasive sensor, backed by $19M in new funding.
+9
Aug 26, 2025
The future of insulin delivery is tubeless, screenless, phoneless—and even movement-tracking. Here are the devices in development you need to know about.
News
Aug 22, 2025
ViCentra brings smartphone control and Dexcom G7 integration to Kaleido, powered by Diabeloop’s DBLG2 algorithm.
Aug 18, 2025
Tandem’s SteadiSet 7-day infusion set received FDA 510(k) clearance and is expected to release on multiple pumps next year.
Aug 11, 2025
Medtronic's new CGM built by Abbott is 510(k) pending and under FDA review, signaling major changes ahead for MiniMed insulin pumps.
Jul 29, 2025
The tubeless add-on for Tandem's Mobi insulin pump will give users an untethered wear option and challenge competitors to innovate faster.
Jul 22, 2025
Tandem’s SteadiSet received FDA 510(k) clearance for 7-day wear and is expected to release in 2026 for multiple pumps.
Dexcom
+4
Jul 21, 2025
I speak with Dexcom about recent sensor failures and receiver recalls, how the company is responding, and what’s next—including new G7 app features and the upcoming 15-day sensor.
+1
Jul 17, 2025
The star of Black-ish opens up about his diabetes journey and shares how laughter—and a little technology—can go a long way.
Jul 8, 2025
From tubeless pumps to a dual glucose-ketone sensor and cell therapy breakthroughs—ADA 2025 delivered game-changing updates in diabetes tech. Here's what stood out.
CGM
Jun 25, 2025
A new CGM deal moves PharmaSens one step closer to creating a fully self-contained insulin pump and CGM.
Jun 24, 2025
The pump currently in development allows users to change sites without a phone—potentially reshaping the tubeless landscape and pushing rivals to move faster.
Jun 22, 2025
Smartwatch bolusing, advanced occlusion detection, and CGM integration set the stage for Sequel Med Tech’s game-changing debut.
Jun 20, 2025
Abbott’s flagship CGM now powers Tandem’s Control-IQ+ system—with more pump integrations and a ketone sensor on the horizon.
+7
Tandem, Beta Bionics, Sequel Med Tech, and Ypsomed are the first to announce integration plans for Abbott’s dual-analyte sensor with more expected.
Jun 9, 2025
Tandem Diabetes is already telling patients its smartphone app to control the Mobi insulin pump will arrive by the end of 2025.
May 21, 2025
The diabetes division will separate from its parent company. Could this unlock faster innovation—or is it more of the same with a new name?
May 5, 2025
The company will now open the waitlist for its newly FDA cleared CGM to current users after user feedback.
Apr 29, 2025
Sequel Med Tech announces support for the Eversense CGM as it prepares for the twiist insulin pump launch. Here's what you need to know.
Apr 21, 2025
Abbott's new app brings much needed upgrades like silence Low Alarms and control of all sensors under one umbrella.
Apr 16, 2025
The major insulin pump manufacturer sent out a survey asking its users which color they prefer for its upcoming tubeless pump.
